Litigation Details for Exeltis USA, Inc. v. Lupin Ltd. (D. Del. 2022)
✉ Email this page to a colleague
Exeltis USA, Inc. v. Lupin Ltd. (D. Del. 2022)
Docket | ⤷ Sign Up | Date Filed | 2022-04-01 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Richard Gibson Andrews |
Jury Demand | Referred To | Mary Pat Thynge | |
Patents | 10,179,140; 9,603,860 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Exeltis USA, Inc. v. Lupin Ltd.
Details for Exeltis USA, Inc. v. Lupin Ltd. (D. Del. 2022)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2023-02-28 | 107 | Opinion - Memorandum Opinion | U.S. Patent No. 9,603,860 (the “’860 patent”), U.S. Patent No. 10,179,140 (the “’140 patent”), U.…construction for multiple terms in U.S. Patent Nos. 9,603,860, 10,179,140, 10,987,364, 11,123,299, 11,291,632…U.S. Patent No. 10,987,364 (the “’364 patent”), U.S. Patent No. 11,123,299 (the “’299 patent”), U.…U.S. Patent No. 11,291,632 (the “’632 patent”), U.S. Patent No. 11,291,633 (the “’633 patent”), U.…U.S. Patent No. 11,351,122 (the “’122 patent”), U.S. Patent No. 11,413,249 (the “’249 patent”), U. | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |